Dr Arjun Goyal
InvestorManaging Director at Vida Ventures Β· Investment Committee at Tin Alley Ventures Β· Board director at Third Arc Bio Β· Board director at Alterome Therapeutics, Inc. Β· Board director at Scorpion Therapeutics
Boston, Massachusetts, United States
About
Arjun Goyal is a co-founder and former managing director of Vida Ventures, a US-based life sciences venture firm with over US$1.7 billion in assets under management. He studied Medicine and conducted malaria vaccine development research at the University of Oxford, then completed Bioscience Enterprise at Cambridge and an MBA at Harvard. He is involved in the Australian biotech community and has helped US biotech companies begin clinical trials in Australia.
Invests in
Biotech
Board director at Third Arc Bio
Intro paths
β
In turn, Dr can intro founders to Third Arc Bio's investors below.
Third Arc Bio's investors Β· 8
abrdn plcEdinburgh Β· since 2026Andreessen HorowitzMenlo Park Β· $500K β $50M checks Β· since 2024Biotechnology Value FundSan Francisco Β· since 2026Foresite CapitalWest Hollywood Β· since 2024Hillhouse InvestmentSingapore Β· since 2026Omega FundsBoston Β· since 2024T. Rowe PriceBaltimore Β· since 2026Vida VenturesLos Angeles Β· since 2024
Board director at Alterome Therapeutics, Inc.
Intro paths
β
In turn, Dr can intro founders to Alterome Therapeutics, Inc.'s investors below.
Alterome Therapeutics, Inc.'s investors Β· 6
Canaan PartnersStamford Β· $500K β $20M checks Β· since 2021Digitalis VenturesNew York Β· $100K β $10M checks Β· since 2021Nextech InvestZurich Β· $648K β $3.2M checks Β· since 2021NVIDIASanta Clara Β· since 2021OrbiMedNew York Β· $1M β $75M checks Β· since 2021Vida VenturesLos Angeles Β· since 2021
Co-founders at Alterome Therapeutics, Inc.
EA
Eric A. MurphyExecutive Officer, Director, Promoter
Board director at Scorpion Therapeutics
Intro paths
β
In turn, Dr can intro founders to Scorpion Therapeutics's investors below.
Scorpion Therapeutics's investors Β· 9
Atlas VentureCambridge Β· $500K β $1M checks Β· since 2024Avoro Capital AdvisorsNew YorkEcoR1 CapitalSan Francisco Β· since 2024Frazier Life SciencesPalo AltoLightspeed Venture PartnersMenlo Park Β· $1.7M β $87M checksNextech InvestZurich Β· $648K β $3.2M checksOlive Tree CapitalBostonOmega FundsBoston Β· since 2024Vida VenturesLos Angeles
Co-founders at Scorpion Therapeutics
AF
Adam FriedmanExecutive Officer, Director
GG
Gary GlickExecutive Officer, Director
Experience
- Vianti CapitalFounder and Managing Partnercurrent2025 β presentBoston, Massachusetts, United States
- Centessa PharmaceuticalsMember Board Of Directorscurrent2021 β presentBoston, Massachusetts, United States
- Harvard Business SchoolVenture Capital Advisor & Program Advisor MS/ MBA Life Sciences Programcurrent2022 β presentBoston, Massachusetts, United States
- Vida Ventures, LLCCo-Founder and Managing Director2017 β 2025Boston and Los Angeles
- Scorpion TherapeuticsMember Board Of Directors2020 β 2025Boston and San Francisco
- Halda TherapeuticsMember Board of Directors2024 β 2025New Haven, Connecticut, United States
- Alterome Therapeutics, IncMember Board Of Directors2021 β 2025San Diego, California, United States
- Affini-T TherapeuticsCo-Founder and Board Member2021 β 2025Boston and Seattle
- Quanta TherapeuticsMember Board Of Directors2020 β 2025San Francisco, California, United States
- Pionyr ImmunotherapeuticsMember Board Of Directors2017 β 2021
- Kinnate Biopharma Inc.Member Board Of Directors2019 β 2020San Diego, California, United States
- Asklepios BioPharmaceutical, Inc. (AskBio)Investor2018 β 2020Raleigh, North Carolina, United States
- Peloton Therapeutics, IncInvestor2019 β 2020Dallas, Texas, United States
- 5AM VenturesPrincipal2014 β 2017Boston, MA & Menlo Park, CA
- Entrada TherapeuticsBoard Observer and Founding Team2016 β 2017Boston, Massachusetts, United States
- APREA THERAPEUTICS ABBoard Observer2016 β 2017Stockholm, Stockholm County, Sweden
- Pear TherapeuticsBoard Observer2016 β 2017Boston, MA & San Francisco, CA
- Pear TherapeuticsInterim Vice President, Corporate Development2014 β 2016Boston, MA
- Portal InstrumentsBoard Observer2015 β 2017Boston, MA
- SPYRYX BiosciencesBoard Observer2015 β 2017Raleigh-Durham-Chapel Hill Area
- Homology Medicines, Inc.Board Observer and Founding Team2015 β 2017Boston, Massachusetts, United States
- Cleave Biosciences, Inc.Board Observer2014 β 2015San Francisco County, California, United States
- Foresight PharmaceuticalsCo-Founder2009 β 2014Greater Cambridge Area
- LazardLife Sciences M&A MBA Summer Associate2013San Francisco, California, United States
- Royal Prince Alfred HospitalResident (Oncology)2011 β 2012Greater Sydney Area
- Celtic Therapeutics HoldingsInvestment Intern2009New York
- Westmead HospitalInternship and Residency in Internal Medicine/Oncology2007 β 2008Greater Sydney Area
- Australian MIssion to the United NationsECOSOC Intern2005 β 2006New York
Skills & more
Medical Education24Clinical Research34Healthcare45Internal Medicine10Medicine16Entrepreneurship98Oncology42Public Health10Research11Medical Devices18Venture Capital86Biotechnology24
+10 more
Corporate DevelopmentLifesciencesStart-upsFinancial ModelingPrivate EquityLife SciencesMergers & AcquisitionsClinical DevelopmentStrategyPharmaceutical IndustryLanguages English Β· French
From Dr's professional profile.
Colleagues at Vida Ventures
Alessandro Giacometti
Vice President, Head of Investor Relations at Vida Ventures
Alex Loftis
Principal at Vida Ventures
Alex Mejia
Executive Services Manager at Vida Ventures
Alex Shen
Director of Operations at Vida Ventures
Andy Kadlec
Senior Associate at Vida Ventures
Anita Keenan
Executive Assistant at Vida Ventures
Arie Belldegrun
Founder and Senior Managing Director at Vida Ventures
Brian Goodman
Managing Director at Vida Ventures
Network5
Albert Cha
Managing Partner at Frazier Life Sciences
Jean-François Formela
Partner at Atlas Venture
Mark Springel
Principal at Vida Ventures
Rajul Jain
Managing Director at Vida Ventures
Tim Shannon
General Partner at Canaan Partners
Investors connected to Dr in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Dr Arjun Goyal?
- Arjun Goyal is a co-founder and former managing director of Vida Ventures, a US-based life sciences venture firm with over US$1.7 billion in assets under management. He studied Medicine and conducted malaria vaccine development research at the University of Oxford, then completed Bioscience Enterprise at Cambridge and an MBA at Harvard. He is involved in the Australian biotech community and has helped US biotech companies begin clinical trials in Australia.
- Where does Dr Arjun Goyal work?
- Dr Arjun Goyal is Managing Director at Vida Ventures and Board director at Third Arc Bio and Board director at Alterome Therapeutics, Inc. and Board director at Scorpion Therapeutics.
- What does Dr Arjun Goyal invest in?
- Dr Arjun Goyal invests in Biotech.
- Where did Dr Arjun Goyal go to school?
- Dr Arjun Goyal studied at Harvard Business School (MBA, Business Administration); University of Cambridge (Master of Philosophy, Bioscience Enterprise); University of Oxford (Bachelor Medical Science, Malaria Vaccine Development).
Founder mafias
Harvard Business School mafia323
Also came through, then founded or led a company.
Mike Maples JrMBAFounded Pattern BreakersHristo BorisovOPM Class 64Founded PayhawkNoubar AfeyanVisiting LecturerFounded ProFound Therapeutics +12Wade MyersMBAFounded RealManage +5Harry GrunerFounded Hilos +2Ellen RubinMBAFounded ClearSky Data +2
+ 316 more
University of Oxford mafia290
Also came through, then founded or led a company.
Reid HoffmanM.St.Founded LinkedIn +2Gabriel PereyraDropped outFounded HarveyBrent HobermanMaster of Arts - MAFounded Founders Pledge +3William GuttmanM.PhilFounded CurvePoint +3Kevin HartzMstFounded Eventbrite +2Max AhrensDoctor of Philosophy - PhDFounded Maihem +2
+ 283 more
University of Cambridge mafia256
Also came through, then founded or led a company.
Stewart ButterfieldMPhilFounded Flickr +1Demis HassabisBAFounded Google Deepmind +2Immad AkhundMaster of Arts (M.A.)Founded Clickpass +2Inaki BerenguerPhDFounded InfiniteWatch +2Harish AgarwalMaster of Philosophy - MPhilFounded Nori +2Nikola MrkΕ‘iΔDoctor of Philosophy (Ph.D.)Founded Poly +2
+ 249 more
University of Melbourne mafia24
Also came through, then founded or led a company.
Cameron AdamsLLB/BScFounded CanvaNikhil PooviahBachelor of MedicineFounded Osara Health +1Haakon BrunellBachelor of Science - BSFounded Katapult Accelerator +1Kenneth DarmansjahBachelor of Commerce (B.Com.)Founded Soul ParkingEd HooperScienceFounded OmnystudioSimon BednarBachelorFounded Finsure
+ 17 more
5AM Ventures mafia4
Also came through, then founded or led a company.
Same school
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesTim DraperFounder of Draper AssociatesMamoon HamidPartner at Kleiner PerkinsNeeraj AgrawalGeneral Partner at Battery VenturesHristo BorisovCo-founder & CEO of Payhawk
+ 1,994 more
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 887 more
Also attended University of Oxford990
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 984 more
Also attended Sydney Grammar School12
Zi-Yang LimHead of Legal at Jungle VenturesJoel BreuerAssociate at Level EquityAsh ClearyPrincipal at LDV CapitalNick LakeDirector at EnergyLabStephan KantharajahCo-Founder, Restocq at TiE Women Global Pitch CompetitionChris CominoHead of Investor Relations at Folklore Ventures
+ 6 more
.jpg)
